Canonpharma Production

Canonpharma Production, established in 1998, is a prominent pharmaceutical entity operating within the Russian healthcare sector. The company specializes in the research, development, and manufacturing of high-quality medications, maintaining a robust portfolio of over 400 distinct pharmaceutical products. By focusing on critical therapeutic areas such as neurology, cardiology, and oncology, the organization addresses diverse medical needs while ensuring strict adherence to international Good Manufacturing Practice (GMP) standards.

With a workforce of 500-1,000 employees, Canonpharma Production maintains a significant operational footprint across 3 distinct locations. The company leverages its technical expertise to provide safe and effective treatments, prioritizing accessibility for patients and healthcare professionals alike. Their commitment to pharmaceutical innovation is reflected in their long-standing history of over 27 years, during which they have consistently expanded their production capabilities to meet evolving market demands in the competitive healthcare landscape.

The organizational structure at Canonpharma Production is designed to support large-scale pharmaceutical manufacturing and distribution. Meet Canonpharma Production's team to understand the leadership and professional expertise driving their ongoing development initiatives. By integrating advanced production technologies with a dedicated workforce, the company continues to solidify its position as a reliable provider of modern medical solutions. Their strategic focus remains on delivering high-quality therapeutic outcomes while maintaining operational excellence across all manufacturing facilities in the Moscow Oblast region.